"SLT is a widely used first-line laser therapy for glaucoma but relies on a Q-switched Nd:YAG laser, which induces cellular ...

The study, conducted at the University Eye Clinic Maastricht, aimed to assess the effectiveness, repeatability, and safety of retreatment in real-world clinical practice using MicroPulse TLT. The ...

Laser treatment has the potential to transform the management of glaucoma in Africa, and to prevent more people from going irreversibly blind, particularly in regions with high disease prevalence and ...

Stead added that while SLT is now the first treatment that is offered to patients, a range of topical medications in the form ...

Iridex (IRIX) announced a recently published independent, retrospective study in Ophthalmology and Therapy. The study demonstrates that ...

Laser treatment has the potential to transform the management of glaucoma in Africa, and to prevent more people from going irreversibly blind, particularly in regions with high disease prevalence and ...

ViaLase announced the first patient was treated in a U.S. IDE clinical trial evaluating its femtosecond laser trabeculotomy ...

Belkin Laser, a small Israel-based biotechnology company, has announced that it has completed enrollment for its pivotal, Phase III trial investigating a new, laser-based treatment option for patients ...

Medication, laser, and surgery are all methods of treating glaucoma according to Jonathan Eisengart, MD. Jonathan Eisengart, MD, an ophthalmologist at Cleveland Clinic, explained how different ...

About 3 million people in the United States have glaucoma, and it’s the second leading cause of blindness worldwide, according to the Centers for Disease Control and Prevention. While there is no cure ...

Please provide your email address to receive an email when new articles are posted on . Frailty and older age are associated with significantly lower odds of undergoing surgery or laser treatment for ...